High affinity HIV nucleocapsid nucleic acid ligands
First Claim
Patent Images
1. A purified and isolated non-naturally occurring nucleic acid ligand to HIV-1 nucleocapsid.
4 Assignments
0 Petitions
Accused Products
Abstract
Methods are described for the identification and preparation of high-affinity nucleic acid ligands to HIV-1 nucleocapsid. Included in the invention are specific RNA ligands to HIV-1 nucleocapsid identified by the SELEX method and RNA ligands that inhibit the function of HIV-1 nucleocapsid.
-
Citations
7 Claims
- 1. A purified and isolated non-naturally occurring nucleic acid ligand to HIV-1 nucleocapsid.
-
5. A nucleic acid ligand to HIV-1 nucleocapsid identified according to the method comprising:
-
a) preparing a candidate mixture of nucleic acids; b) contacting the candidate mixture of nucleic acids with HIV-1 nucleocapsid, wherein nucleic acids having an increased affinity to HIV-1 nucleocapsid relative to the candidate mixture may by partitioned from the remainder of the candidate mixture; c) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; and d) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched for nucleic acid sequences with relatively higher affinity and specificity for binding to HIV-1 nucleocapsid, whereby "a nucleic acid ligand" of HIV-1 nucleocapsid may be identified. - View Dependent Claims (6)
-
Specification